Suning Chen, Yu Wu, Jianyu Weng, Cheng Zhang, Hongsheng Zhou, Vadim Doronin, Mei Hong, Ying Wang, Xudong Wei, Iurii Osipov, Yulia Alexeeva, Zi Chen, Yanyan Wang, Lichuang Men, Hengbang Wang, Lixin Jiang, Dengkun Xiong, Dajun Yang, Weili Zhao, Yifan Zhai. "Results of POLARIS-1, a global Phase 3 study (Part A): Olverembatinib combined with low-intensity chemotherapy in patients with newly diagnosed (ND) Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL)." Blood, 2025. doi:10.1182/blood-2025-1574